Healthcare seems to be the keyword for tech companies these days, with most including Apple bringing out products and services to improve the longevity of mankind (God, save our users!). IT-services major Cognizant is now expanding its reach into the healthcare sector with its intention to acquire Bolder Healthcare Solutions.
Bolder is a private firm that offers revenue cycle management solutions to hospitals and specialty care providers. Through this transaction, which is expected to close in the second quarter of the year, Cognizant plans to expand its services to more hospitals and healthcare providers.
Bolder acquisition will create value for all the shareholders, as a report from Zion Market Research indicated, the global revenue cycle management is expected to grow to around $43.80 billion by 2022 from $23.40 billion in 2016. Also, a major chunk of the market share is expected to come from North America, which poses an enormous advantage for Cognizant as over 70% of its revenue is derived from this region.
IT-services major Cognizant is now expanding its reach into the healthcare sector with its intention to acquire Bolder Healthcare Solutions.
Cognizant derives most of its revenue from two industries: Financial services and healthcare business. Over the past few years, Cognizant has been pretty serious with its healthcare business, as it accounts for almost 30% of the company’s total revenue. In the latest fourth quarter, the company reported 12% growth in its revenue from healthcare business.
Cognizant’s largest healthcare deal occurred in 2014 when the company purchased TriZetto for $2.7 billion, which was followed by the acquisition of TMG Health.
Tyson Foods Inc. (NYSE: TSN) reported first quarter 2023 earnings results today. Sales rose 2.5% year-over-year to $13.2 billion. Net income attributable to Tyson was $316 million, or $0.88 per
Apple Inc. (NASDAQ: AAPL) this week reported its first revenue decline in more than three years, even as the high inflation continues to squeeze customers’ spending power. Sales of the
Chipmaker Qualcomm, Inc. (NASDAQ: QCOM) has reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for the second quarter of 2023. At $9.5